Cargando…
Pyridoindole SMe1EC2 as cognition enhancer in ageing-related cognitive decline
Synthetic pyridoindole-type substances derived from the lead compound stobadine represent promising agents in treatment of a range of pathologies including neurological disorders. The beneficial biological effects were suggested to be likely associated with their capacity to ameliorate oxidative dam...
Autores principales: | Mrvová, Nataša, Škandík, Martin, Bezek, Štefan, Sedláčková, Natália, Mach, Mojmír, Gaspárová, Zdenka, Luptáková, Dominika, Padej, Ivan, Račková, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Slovak Toxicology Society SETOX
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096865/ https://www.ncbi.nlm.nih.gov/pubmed/30123031 http://dx.doi.org/10.1515/intox-2017-0002 |
Ejemplares similares
-
Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model
por: Sedláčková, Natália, et al.
Publicado: (2011) -
Safety assessment of the pyridoindole derivative SMe1EC2: developmental neurotoxicity study in rats
por: Ujházy, Eduard, et al.
Publicado: (2011) -
The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia-induced impairment of longterm potentiation in rat hippocampus
por: Gáspárová, Zdenka, et al.
Publicado: (2011) -
Oxidative stress induced by the Fe(2+)/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue
por: Gáspárová, Zdenka, et al.
Publicado: (2010) -
Antioxidant action of SMe1EC2, the low-basicity derivative of the pyridoindole stobadine, in cell free chemical models and at cellular level
por: Balcerczyk, Aneta, et al.
Publicado: (2014)